Condition
Not applicable (submitted trial is a bioavailability trial in healthy participants).
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Phase 1 (3)
Trial Status
Unknown2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
SYF1afb25b5fc4441ac8a1dc7429c298c75Phase 1Not Yet Recruiting
Bioequivalence of Estradiol 10 mcg Vaginal Tablets in Healthy Women Participants.
SYF94e6ce2c1dd04657a8d1cd6e40368966Phase 1Unknown
Bioequivalence of Tramadol retard 200 mg Prolonged-Release Tablets in Healthy Subjects Under Fed Conditions
SYFc31a6662f96b47e5a5e61cf3601062b1Phase 1Unknown
Bioequivalence of Tramadol retard 200 mg Prolonged-Release Tablets in Healthy Participants Under Fasting Conditions
Showing all 3 trials
Research Network
Active Sponsors
- Laboratorios Cinfa S.A.2
- Laboratorios Leon Farma S.A.1